BIOMAT Database Logo BIOMAT Database Logo

In vitro induction of cytotoxic T lymphocytes against HTLV-I-infected T-cells from adult T-cell leukemia patients, asymptomatic HTLV-I carriers and seronegative healthy donors. 1995

Y Katahira, and S Yashiki, and T Fujiyoshi, and K Nomura, and M Tara, and M Mori, and M Setoyama, and T Kanzaki, and H Shida, and S Sonoda
Department of Dermatology, Faculty of Medicine, Kagoshima University.

We investigated an in vitro method to produce cytotoxic T lymphocytes (CTLs) against HTLV-I-infected T-cells using peripheral blood mononuclear cells (PBMC) of adult T-cell leukemia (ATL) patients, asymptomatic HTLV-I carriers (AC) and seronegative healthy donors. The PBMC were restimulated repeatedly for 4 weeks with HLA-matched HTLV-I-infected T-cells which had been pretreated at 56 degrees C for 30 min to inactivate infectious HTLV-I. The culture medium included 10-100 units/ml of recombinant lymphokines (rIL-1, rIL-2, rIL-4, rIL-6 and rIL-7) and 10% fetal calf serum in RPMI-1640 medium. The cytotoxic activity was measured against HLA-matched HTLV-I-infected T-cell lines after CD4+ or CD8+ cells were positively panned from the cultured PBMC. The PBMC of ATL, AC and healthy donors were able to produce either CD4+ or CD8+ CTLs against HTLV-I-related antigens (env, gag, p21x, p27rex and p40tax) as well as the antigen(s) of as-yet unknown specificity expressed on HTLV-I-infected T-cells. All the CTLs recognized the specific antigens in the context of either class I or class II HLA types. These results indicated that ATL patients, AC and healthy donors were immunocompetent to generate CTLs against HTLV-I-infected T-cells and probably against HTLV-I-transformed T-cells.

UI MeSH Term Description Entries
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006358 Hot Temperature Presence of warmth or heat or a temperature notably higher than an accustomed norm. Heat,Hot Temperatures,Temperature, Hot,Temperatures, Hot
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000939 Epitopes Sites on an antigen that interact with specific antibodies. Antigenic Determinant,Antigenic Determinants,Antigenic Specificity,Epitope,Determinant, Antigenic,Determinants, Antigenic,Specificity, Antigenic
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte

Related Publications

Y Katahira, and S Yashiki, and T Fujiyoshi, and K Nomura, and M Tara, and M Mori, and M Setoyama, and T Kanzaki, and H Shida, and S Sonoda
Effect of human serum anti-HTLV antibodies on viral antigen induction in vitro cultured peripheral lymphocytes from adult T-cell leukemia patients and healthy virus carriers.
July 1985, International journal of cancer,
Y Katahira, and S Yashiki, and T Fujiyoshi, and K Nomura, and M Tara, and M Mori, and M Setoyama, and T Kanzaki, and H Shida, and S Sonoda
[IgM anti-ATLA antibodies in HTLV-I healthy carriers and patients with adult T cell leukemia and HTLV-I associated myelopathy].
April 1988, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
Y Katahira, and S Yashiki, and T Fujiyoshi, and K Nomura, and M Tara, and M Mori, and M Setoyama, and T Kanzaki, and H Shida, and S Sonoda
[Localization of HTLV-I-associated antigens in adult T cell leukemia cells and HTLV-I-infected cell line cells].
February 1991, Nihon Hifuka Gakkai zasshi. The Japanese journal of dermatology,
Y Katahira, and S Yashiki, and T Fujiyoshi, and K Nomura, and M Tara, and M Mori, and M Setoyama, and T Kanzaki, and H Shida, and S Sonoda
Immune suppression in healthy carriers of adult T-cell leukemia retrovirus (HTLV-I): impairment of T-cell control of Epstein-Barr virus-infected B-cells.
July 1987, Japanese journal of cancer research : Gann,
Y Katahira, and S Yashiki, and T Fujiyoshi, and K Nomura, and M Tara, and M Mori, and M Setoyama, and T Kanzaki, and H Shida, and S Sonoda
Recognition of human T cell leukemia virus type I (HTLV-I) gag and pX gene products by MHC-restricted cytotoxic T lymphocytes induced in rats against syngeneic HTLV-I-infected cells.
June 1990, Journal of immunology (Baltimore, Md. : 1950),
Y Katahira, and S Yashiki, and T Fujiyoshi, and K Nomura, and M Tara, and M Mori, and M Setoyama, and T Kanzaki, and H Shida, and S Sonoda
HTLV-I provirus in seronegative healthy blood donors.
April 1997, Lancet (London, England),
Y Katahira, and S Yashiki, and T Fujiyoshi, and K Nomura, and M Tara, and M Mori, and M Setoyama, and T Kanzaki, and H Shida, and S Sonoda
Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells.
August 1991, International immunology,
Y Katahira, and S Yashiki, and T Fujiyoshi, and K Nomura, and M Tara, and M Mori, and M Setoyama, and T Kanzaki, and H Shida, and S Sonoda
HTLV-I-seronegative, genome-positive adult T-cell leukemia: report of a case.
October 1996, American journal of hematology,
Y Katahira, and S Yashiki, and T Fujiyoshi, and K Nomura, and M Tara, and M Mori, and M Setoyama, and T Kanzaki, and H Shida, and S Sonoda
Comparison of HTLV-I Proviral Load in Adult T Cell Leukemia/Lymphoma (ATL), HTLV-I-Associated Myelopathy (HAM-TSP) and Healthy Carriers.
March 2013, Iranian journal of basic medical sciences,
Y Katahira, and S Yashiki, and T Fujiyoshi, and K Nomura, and M Tara, and M Mori, and M Setoyama, and T Kanzaki, and H Shida, and S Sonoda
[Morphological studies on cells from adult T cell leukemia. II. Lobulated lymphocytes and HTLV-I infection].
April 1987, Rinsho byori. The Japanese journal of clinical pathology,
Copied contents to your clipboard!